These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19204767)

  • 1. Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study.
    Crocco A; D'Elia D
    Blood Transfus; 2007 Jul; 5(3):143-52. PubMed ID: 19204767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions in whole blood donors: an Indian scenario.
    Pathak C; Pujani M; Pahuja S; Jain M
    Blood Transfus; 2011 Jan; 9(1):46-9. PubMed ID: 21084010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions in blood donors with a history of seizures or epilepsy.
    Krumholz A; Ness PM; Hauser WA; Douglas DK; Gibble JW
    Transfusion; 1995 Jun; 35(6):470-4. PubMed ID: 7770896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Reactions in Allogeneic Blood Donors: A Tertiary Care Experience from a Developing Country.
    Sultan S; Baig MA; Irfan SM; Ahmed SI; Hasan SF
    Oman Med J; 2016 Mar; 31(2):124-8. PubMed ID: 27168923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018).
    Orru' S; Poetzsch K; Hoffelner M; Heiden M; Funk MB; Keller-Stanislawski B; Oberle D
    Transfus Med Hemother; 2021 Oct; 48(5):272-283. PubMed ID: 34803571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance.
    Wiersum-Osselton JC; Politis C; Richardson C; Goto N; Grouzi E; Marano G; Land KJ
    Vox Sang; 2021 Jul; 116(6):628-636. PubMed ID: 33278040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
    Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
    Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of Platelet Count among Apheresis Platelet Donors.
    Thokala RP; Radhakrishnan K; Anandan A; Panicker VK
    J Clin Diagn Res; 2016 Dec; 10(12):EC01-EC04. PubMed ID: 28208861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events and retention of donors of double red cell units by apheresis.
    Keshelashvili K; O'meara A; Stern M; Jirout Z; Pehlic V; Holbro A; Buser A; Sigle J; Infanti L
    Blood Transfus; 2016 Sep; 14(5):391-9. PubMed ID: 27136442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds.
    Eder AF; Hillyer CD; Dy BA; Notari EP; Benjamin RJ
    JAMA; 2008 May; 299(19):2279-86. PubMed ID: 18492969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of adverse whole blood donor reactions in normal healthy blood donors: experience of tertiary health care centre in jammu region.
    Dogra A; Sidhu M; Dogra M; Raina TR
    Indian J Hematol Blood Transfus; 2015 Mar; 31(1):142-5. PubMed ID: 25548461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Store of Repeat Plasma and Platelet Apheresis Donors.
    Pfeiffer H; Hechler J; Zimmermann R; Hackstein H; Achenbach S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.